智慧药丸技术市场规模、份额和成长分析（按目标领域、适应症、应用、最终用户和地区划分）—产业预测（2026-2033 年）

全球智慧药丸技术市场规模预计在 2024 年达到 42.3 亿美元，从 2025 年的 45.9 亿美元增长到 2033 年的 88.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.5%。

全球智慧药丸技术市场正见证着创新数位胶囊在先进感测、成像和药物传输领域的广泛应用。这些胶囊配备有生物感测器和pH感测器等多种感测器，可在胃肠道内移动，捕捉传统方法难以取得的重要诊断影像。此外，可连接的可穿戴感测器贴片，结合医疗服务提供者的入口网站和行动应用程序，增强了监测能力，并为内视镜等传统诊断技术提供了非侵入性替代方案，尤其是在癌症和胃肠道疾病的诊断方面。智慧药丸还能提高患者的用药依从性，并有助于评估胃轻瘫等胃肠道疾病。这些技术能够无线传输包括生命征象和胃肠道指标在内的关键数据，正在革新患者的诊断和管理，为医疗服务提供者带来更大的柔软性。

全球智慧药丸技术市场驱动因素

由于胃肠道疾病（包括动力障碍、大肠直肠癌、不明原因的消化道出血和克隆氏症）的发生率不断上升，全球智慧药丸技术市场预计将迎来显着增长。此外，久坐不动的生活方式也推动了医疗保健领域对创新解决方案的需求。智慧药丸的优点在于其微创性，有助于提高患者的依从性。随着技术的不断进步，这些因素共同推动了人们对智慧药丸解决方案的兴趣，使其成为旨在改善患者预后和提高治疗效率的现代医疗保健策略的关键组成部分。

全球智慧药丸技术市场面临的限制因素

儘管这项创新技术具有诸多优势，但全球智慧药丸技术市场的发展仍面临一些挑战。主要障碍包括胶囊内视镜技术进步有限以及患者对吞服微晶片的担忧。此外，可吞服感测器的高成本以及监管机构对这些设备更广泛应用的严格监管措施也是一大障碍。这些因素综合起来，预计将限制市场成长潜力，并阻碍智慧药丸技术在医疗保健领域的更广泛应用和整合。

全球智慧药丸技术市场趋势

全球智慧药丸技术市场正经历显着成长，这主要得益于人工智慧物联网解决方案（例如智慧药丸提取系统 (SPES)）的进步。这个创新平台可自动管理药物，同时提升易用性和即时诊断支持，有效解决药物依从性差的问题——药物依从性差是阻碍患者康復并增加医疗成本的一大难题。 SPES 相容于多种环境，包括养老院和居家医疗，并可同时有效管理多个用户，方便家庭成员和医护人员进行持续监测。该系统故障率极低，并具备强大的用户身份验证功能，优先考虑个人化用药和可靠的健康预测，从而在医疗效率和患者安全方面树立了新的标竿。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 一手和二手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析
• 监管分析
• 专利分析
• 用例

全球智慧药丸技术市场规模（依目标身体部位划分）及复合年增长率（2026-2033 年）

• 食道
• 胃
• 小肠
• 冒号

全球智慧药丸技术市场规模（按适应症和复合年增长率划分）（2026-2033 年）

• 巴瑞特氏食道症
• 小肠疾病
• 结肠癌
• 其他的

全球智慧药丸技术市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 胶囊内视镜
• 药物输送
• 病患监测
• 其他的

全球智慧药丸技术市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

• 医院和诊所
• 诊断中心
• 研究中心

全球智慧药丸技术市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • GCC
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

  主要企业简介

  • IntroMedic有限公司（韩国）
  • CapsoVision公司（美国）
  • Koninklijke Philips NV（荷兰）
  • 奥林巴斯株式会社（日本）
  • RF株式会社（日本）
  • HQ公司（美国）
  • Proteus Digital Health（美国）
  • 美敦力公司（爱尔兰）
  • 重庆金山科技（集团）有限公司（中国）
  • 检查-Cap 有限公司（以色列）
  • AnX Robotica 公司（美国）
  • 深圳市吉福医疗科技有限公司（中国）
  • etecRx（美国）
  • BodyCap（法国）
  • 大冢美国製药公司（美国）
  • GE医疗（美国）
  • 波士顿科学公司（美国）
  • Given Imaging Ltd.（现为美敦力公司的一部分）（以色列）
  • Bio-Images Research Limited（英国）
  • Lucid Diagnostics（美国）

结论与建议

Global Smart Pills Technology Market size was valued at USD 4.23 Billion in 2024 and is poised to grow from USD 4.59 Billion in 2025 to USD 8.82 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global smart pill technology market showcases innovative digital capsules designed for advanced sensing, imaging, and medication delivery. These capsules, equipped with various sensors like biosensors and pH sensors, navigate the gastrointestinal tract, capturing essential diagnostic images that are difficult to access through conventional methods. Additionally, a connected wearable sensor patch enhances monitoring by linking to a provider portal and mobile app, facilitating a non-invasive alternative to traditional diagnostic techniques, such as endoscopy, particularly for cancer and gastrointestinal disorders. Furthermore, smart pills improve medication adherence and allow for the assessment of gastrointestinal conditions like gastroparesis. By wirelessly transmitting critical data, including vital signs and digestive metrics, these technologies revolutionize patient diagnosis and management, offering heightened flexibility for healthcare providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Pills Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Pills Technology Market Segments Analysis

Global Smart Pills Technology Market is segmented by Target Area, Disease Indication, Application, End User and region. Based on Target Area, the market is segmented into Esophagus, Stomach, Small Intestine and Large Intestine. Based on Disease Indication, the market is segmented into Barrett's Esophagus, Small Bowel Diseases, Colon Cancer and Others. Based on Application, the market is segmented into Capsule Endoscopy,Drug Delivery,Patient Monitoring and Others. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Centers and Research Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is poised for significant growth, fueled by the increasing incidence of gastrointestinal disorders, including motility issues, colon cancer, obscure gastrointestinal bleeding, and Crohn's disease. Additionally, the prevalence of sedentary lifestyles contributes to the demand for innovative solutions in healthcare. The appeal of smart pills lies in their ability to enhance patient compliance, attributed to their minimally invasive nature. As advancements in technology continue to evolve, these factors are driving a heightened interest in smart pill solutions, making them an essential component of modern healthcare strategies aimed at improving patient outcomes and treatment efficiency.

Restraints in the Global Smart Pills Technology Market

The growth of the Global Smart Pills Technology market faces several challenges despite the numerous benefits associated with this innovative technology. Key obstacles include limited technological advancements in capsule endoscopes, alongside patients' apprehension regarding the ingestion of microchips. Additionally, the high costs associated with ingestible sensors pose a significant barrier, as well as stringent regulatory measures imposed by authorities governing the increasing application of these devices. Collectively, these factors are anticipated to restrict the market's potential for expansion, hindering the broader adoption and integration of smart pill technology in healthcare practices.

Market Trends of the Global Smart Pills Technology Market

The Global Smart Pills Technology market is witnessing significant growth, driven by advancements in AI-IoT solutions like the Smart Pill Expert System (SPES). This innovative platform automates medication administration while enhancing user-friendliness and real-time diagnostic support, addressing the critical issue of medical non-adherence, which hampers recovery and elevates healthcare costs. By catering to diverse settings such as nursing homes and home healthcare, SPES effectively manages multiple users simultaneously, fostering continuous monitoring by family members and healthcare professionals. With a remarkably low failure rate and robust user authentication, the system prioritizes personalized medication delivery and reliable health predictions, setting a new benchmark in healthcare efficiency and patient safety.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis
• Regulatory Analysis
• Patent Analysis
• Case Studies

Global Smart Pills Technology Market Size by Target Area & CAGR (2026-2033)

• Market Overview
• Esophagus
• Stomach
• Small Intestine
• Large Intestine

Global Smart Pills Technology Market Size by Disease Indication & CAGR (2026-2033)

• Market Overview
• Barrett'S Esophagus
• Small Bowel Diseases
• Colon Cancer
• Others

Global Smart Pills Technology Market Size by Application & CAGR (2026-2033)

• Market Overview
• Capsule Endoscopy
• Drug Delivery
• Patient Monitoring
• Others

Global Smart Pills Technology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Diagnostic Centres
• Research Centres

Global Smart Pills Technology Market Size & CAGR (2026-2033)

• North America (Target Area, Disease Indication, Application, End User)
  • US
  • Canada
• Europe (Target Area, Disease Indication, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Target Area, Disease Indication, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Target Area, Disease Indication, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Target Area, Disease Indication, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• IntroMedic Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CapsoVision, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RF Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HQ, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteus Digital Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc. (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Jinshan Science & Technology (Group) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Check-Cap Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AnX Robotica Corp. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Jifu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• etecRx (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BodyCap (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka America Pharmaceutical, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Given Imaging Ltd. (Now part of Medtronic) (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Images Research Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lucid Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations